Filer Snapshot

Invus Public Equities, L.P. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001340097.

Entity Type

Individual

Total Filings

88

Latest Filing

12 Dec 2024

Industry

n/a

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open reporting owner context
Source: SEC Forms 3/4/5

4 filed on 12 Dec 2024 for CIK 0001340097.

View Source Filing
Business address
C/O The Invus Group, Llc, 750 Lexington Avenue, 30 Th Floor, New York, NY, 10022
Top holdings (ownership)
SRRK, OMGA, and GLYC

Quick Takeaways

  • Invus Public Equities, L.P. is an SEC filer tracked under CIK 0001340097.
  • 88 filings are listed on this profile.
  • Common form coverage includes 4, 3, SC 13G/A and more.

What Changed

  • Latest filing: 4 filed on 12 Dec 2024.
  • Report period: 10 Dec 2024.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC Forms 3/4/5

4 filed on 12 Dec 2024 for CIK 0001340097.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed 4 can change the filing history, ownership context, or next research path for Invus Public Equities, L.P..

Latest source-backed update
4 filed 12 Dec 2024
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: 4 filed 12 Dec 2024.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for Invus Public Equities, L.P.

Ownership report updated

Latest ownership report period: 10 Dec 2024. Open the source-backed page to inspect the fresh filing or facts context.

Update date

12 Dec 2024

Page type

Ownership filings

Latest period

10 Dec 2024

Ownership context was refreshed from SEC Forms 3/4/5 filed on 12 Dec 2024.

Open ownership filings Browse recent public updates

Filer Overview

Invus Public Equities, L.P. has filed 88 SEC EDGAR filings since 30 Sep 2005. Common forms include 4, 3, SC 13G/A, SC 13G and more.

Reporting owner transactions Latest 13F filings

Latest Filings

Recent SEC filings for Invus Public Equities, L.P. with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 12 Dec 2024 10 Dec 2024 001-38501
4 Open 4 document View SEC filing for 4 4 27 Nov 2024 25 Nov 2024 001-38501
4 Open 4 document View SEC filing for 4 4 09 Aug 2024 07 Aug 2024 001-36177
4 Open 4 document View SEC filing for 4 4 07 Aug 2024 05 Aug 2024 001-36177
4 Open 4 document View SEC filing for 4 4 05 Aug 2024 01 Aug 2024 001-36177
4 Open 4 document View SEC filing for 4 4 30 Jul 2024 26 Jul 2024 001-36177
4 Open 4 document View SEC filing for 4 4 14 May 2024 10 May 2024 000-30111
4 Open 4 document View SEC filing for 4 4 13 Mar 2024 13 Mar 2024 000-30111
4 Open 4 document View SEC filing for 4 4 16 Oct 2023 12 Oct 2023 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Jun 2023 05 Jun 2023 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 May 2023 28 Apr 2023 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Feb 2023 24 Feb 2023 001-36177
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 23 Feb 2023 21 Feb 2023 001-36177
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Feb 2023 15 Feb 2023 001-36177
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Feb 2023 09 Feb 2023 001-36177
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 13 Feb 2023 09 Feb 2023 001-36177
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Jan 2023 09 Jan 2023 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jan 2023 05 Jan 2023 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 27 Oct 2022 25 Oct 2022 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 07 Oct 2022 03 Oct 2022 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2022 05 Aug 2022 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 01 Aug 2022 01 Aug 2022 000-30111
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 24 Jun 2022 22 Jun 2022 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2021 30 Jul 2021 001-40657
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 29 Jul 2021 29 Jul 2021 001-40657
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 16 Feb 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Feb 2021 01 Feb 2021 001-39747
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Dec 2020 16 Dec 2020 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 10 Dec 2020 08 Dec 2020 001-39747
3 Open 3 document View SEC filing for 3 FORM 3 03 Dec 2020 03 Dec 2020 001-39747
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 13 Nov 2020
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Nov 2020 03 Nov 2020 001-39662
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 29 Oct 2020 29 Oct 2020 001-39662
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 18 Jun 2020 16 Jun 2020 001-39319
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 11 Jun 2020 11 Jun 2020 001-39319
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 12 Feb 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 29 Jun 2018 27 Jun 2018 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Jun 2018 22 Jun 2018 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 21 Jun 2018 19 Jun 2018 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 18 Jun 2018 14 Jun 2018 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Jun 2018 08 Jun 2018 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 07 Jun 2018 05 Jun 2018 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 04 Jun 2018 25 May 2018 000-30111
4 Open 4 document View SEC filing for 4 4 31 May 2018 29 May 2018 001-38501
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 May 2018 25 May 2018 000-30111
SC 13G Open SC 13G document View SEC filing for SC 13G 09 Feb 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Nov 2017 15 Nov 2017 000-30111
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 14 Nov 2017 10 Nov 2017 000-30111
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 06 Jul 2017
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Nov 2014 26 Nov 2014 000-30111
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A FURIEX PHARMACEUTICALS, INC. NO. 5 14 Feb 2014
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A AUXILIUM PHARMACEUTICALS, INC. NO. 4 14 Feb 2014
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 27 Aug 2013
3 Open 3 document View SEC filing for 3 FORM 3 19 Feb 2013 14 Feb 2013 001-34641
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G/A 19 Feb 2013
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G/A 31 Jan 2013
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G/A 31 Jan 2013
4 Open 4 document View SEC filing for 4 FORM 4 25 Oct 2012 23 Oct 2012 000-30111
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G/A - FURIEX PHARMACEUTICALS, INC. 10 Apr 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G/A - AUXILIUM PHARMACEUTICALS, INC. 10 Apr 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 14 Feb 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 14 Feb 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 13 Feb 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 13 Feb 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 13 Feb 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 13 Feb 2012
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 13 Feb 2012
4 Open 4 document View SEC filing for 4 MAIN DOCUMENT DESCRIPTION 27 Dec 2011 22 Dec 2011 000-30111
SC 13G Open SC 13G document View SEC filing for SC 13G 05 Aug 2011
SC 13G Open SC 13G document View SEC filing for SC 13G 26 Apr 2011

About this filer

Invus Public Equities, L.P. files with the SEC under CIK 0001340097. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .